The acquisition of the majority stake in Bayshore by Ipca Labs' wholly-owned subsidiary will enable the latter to commercialize its registered generics drug products in the US market through this entity.
from India Infoline News Service https://ift.tt/2RkGaiX
No comments:
Post a Comment